Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome |
|---|---|
| Disease/Condition | Blood and Bone Marrow Cancer,Myelodysplastic Syndrome (MDS) |
| Description | |
| Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | Amit Verma, MD |
| Contact Name | Karen Fehn |
| Phone | (718) 405-8446 |
| Contact Email | CPDMUtrialinfo@montefiore.org |
| Protocol Number | OCT11-0092; IRB# 2012-407-000 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
